Eterna Therapeutics Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Eterna Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2024.
  • Eterna Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$24.3M, a 25786% decline year-over-year.
  • Eterna Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$26.2M, a 18405% decline year-over-year.
  • Eterna Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was -$536K, a 106% decline from 2022.
  • Eterna Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $8.68M.
  • Eterna Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was -$8.75M, a 20247% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$26.2M -$24.3M -$24.2M -25786% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$1.94M -$595K -$640K -1422% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$1.3M -$856K -$761K -801% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$536K -$392K -$679K -237% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $143K -$94K -$1.09M -109% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $1.23M $45K -$10.4M -99.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $11.7M -$95K +$2.98M +96.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $8.68M $287K -$347K -54.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $9.03M $993K +$703K +242% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $8.33M $10.5M +$10.6M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$2.23M -$3.08M +$6.52M +67.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$8.75M $634K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 $290K +$303K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$72K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$9.6M Jan 1, 2021 Mar 31, 2021 10-Q 2022-07-01
Q3 2020 -$12.6K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q4 2017 $391K -$105K +$47K +30.9% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-09
Q3 2017 $344K -$122K +$30K +19.7% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $314K -$132K +$17K +11.4% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-04
Q1 2017 $297K $750K +$904K Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-04
Q4 2016 -$607K -$152K -$64K -72.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 -$543K -$152K -$103K -210% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$440K -$149K -$10K -7.19% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 -$430K -$154K -$111K -258% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$319K -$88K +$61K +40.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-09
Q3 2015 -$380K -$49K -$30K -158% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$350K -$139K -$88K -173% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$262K -$43K -$58K -387% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$204K -$149K -$230K -284% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 $26K -$19K -$24K -480% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $50K -$51K -$72K -343% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $122K $15K +$10K +200% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $112K $81K +$40K +97.6% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-27
Q3 2013 $72K $5K +$28K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $44K $21K +$23K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $21K $5K +$37K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$16K $41K +$57K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$73K -$23K -$18K -360% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$55K -$2K -$71K -103% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $16K -$32K -$4K -14.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q4 2011 $20K -$16K Oct 1, 2011 Dec 31, 2011 10-K 2012-03-30
Q3 2011 -$5K +$11K +68.8% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $69K +$132K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$28K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 -$16K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$63K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.